Modular Medical Appoints Industry Veteran Jeff Goldberg to Board of Directors

Rhea-AI Summary

Modular Medical (NASDAQ:MODD) has appointed Jeff Goldberg to its Board of Directors. Goldberg brings extensive experience in healthcare, life sciences, and medical device leadership, particularly in generic insulin development. He currently serves as Chairman of Lannett Company and has a notable background working with MiniMed founder Alfred E. Mann. As President and CEO at IncuMed, Mann's incubator, Goldberg oversaw drug-device combination products, including an insulin patch-pump program.

Goldberg's appointment aligns with Modular Medical's focus on developing user-friendly and affordable insulin delivery technology, as the company has already received FDA clearance for its patch pump designed for "almost-pumpers". His experience in regulatory strategy, operations turnaround, and successful exits positions him well to contribute to Modular Medical's mission of simplifying diabetes care worldwide.

Positive

• Addition of experienced board member with specific expertise in insulin delivery technology and drug-device combinations
• New director brings successful track record in regulatory strategy and operations turnaround
• Strategic alignment with company's focus on affordable insulin delivery solutions

Negative

• None.

SAN DIEGO, CA / ACCESS Newswire / May 28, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to meet the needs of "almost-pumpers" with its user-friendly and affordable design, today announced the appointment of Jeff Goldberg to its Board of Directors. Mr. Goldberg brings decades of experience in health care, life sciences, and medical device leadership, including development of generic insulin. Mr. Goldberg began his work in medical technology alongside pioneering medical entrepreneur, and founder of MiniMed, Alfred E. Mann.

"We are pleased to welcome Jeff Goldberg to the Modular Medical board," said Jeb Besser, CEO of Modular Medical. "Jeff's unique background at the intersection of affordable drug-device combinations will be instrumental, as we advance our mission to simplify insulin delivery and improve diabetes care worldwide."

Mr. Goldberg currently serves as Chairman of Lannett Company, Inc., a generic pharmaceutical manufacturer where he has helped execute a post-restructuring turnaround. During his tenure, Lannett has made significant strides in launching a generic insulin product - progress that aligns closely with Modular Medical's commitment to innovation and affordability in diabetes care.

In addition to his work at Lannett, Mr. Goldberg previously served as President and CEO within Alfred E. Mann's incubator, IncuMed, where he oversaw multiple portfolio companies focused on drug-device combination products, including an insulin patch-pump program. His tenure with Mr. Mann's enterprises included pivotal roles in regulatory strategy, operations turnaround, and successful exits, underscoring his ability to guide early-stage technologies to commercial viability.

"Modular Medical is advancing a truly disruptive approach to insulin delivery," said Mr. Goldberg. "I'm excited to join the board and contribute to the Company's journey toward simplifying treatment for people living with diabetes, particularly as the industry shifts toward more accessible and patient-friendly solutions."

Mr. Goldberg also serves on the boards of several health-care and consumer-focused companies, including ATI Physical Therapy, Cano Health, and Eating Recovery Centers. He holds a JD from UCLA School of Law and an AB from Harvard College.

About Modular Medical

Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its insulin pump. More information is available at https://modular-medical.com.

CONTACT:

Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.

View the original press release on ACCESS Newswire

FAQ

Who is Jeff Goldberg and why did Modular Medical (MODD) appoint him to their board?

Jeff Goldberg is a healthcare industry veteran with extensive experience in medical devices and generic insulin development. He was appointed to Modular Medical's board due to his expertise in drug-device combinations and background working with MiniMed founder Alfred E. Mann.

What is Modular Medical's (MODD) main product focus?

Modular Medical has developed the first FDA-cleared patch pump specifically designed for 'almost-pumpers,' focusing on user-friendly and affordable insulin delivery technology.

What is Jeff Goldberg's current role outside of Modular Medical (MODD)?

Jeff Goldberg currently serves as Chairman of Lannett Company, a generic pharmaceutical manufacturer, and sits on the boards of ATI Physical Therapy, Cano Health, and Eating Recovery Centers.

What experience does Jeff Goldberg bring to Modular Medical's (MODD) board?

Goldberg brings decades of experience in healthcare, life sciences, and medical device leadership, including work on generic insulin development, regulatory strategy, operations turnaround, and successful exits in drug-device combination products.